Measuring the blood levels of anti-CD146 antibodies may help identify people with systemic sclerosis (SSc) whose disease is associated with occupational exposure to silica and other mineral dusts, according to a small study. This is the first biomarker linked to occupational exposure identified in SSc. Detecting these antibodies…
Treatment with AISA-021 (cilnidipine), being developed by Aisa Pharma for Raynaud’s phenomenon, safely reduced the frequency and duration of Raynaud’s attacks in people with systemic sclerosis (SSc). That’s according to recently reported results from the Phase 2 RECONNOITER-1 trial (ACTRN12621000459820) — data that also showed that the…
Hand baths enriched with carbon dioxide (CO2) — a gas that exists naturally in the atmosphere, and is produced by living things breathing out — can significantly widen blood vessels of the fingers in people with systemic sclerosis (SSc)-associated Raynaud’s phenomenon. That’s according to a small clinical trial…
Becoming educated and informed about scleroderma is a good first step. Here you’ll find general information about the disease, including diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your scleroderma journey.
There is no cure for scleroderma yet, but here you can find more information about current therapeutic approaches, as well as experimental treatments that are in the pipeline.
Get regular updates to your inbox.
